Trial NCT00358566

View at ClinicalTrials.gov 
Org. Study IDs: PX115.1.1-302
Secondary IDs: 2005-005014-21

Last trial update was posted on 2008-05-19

MeSH Interventions

Gemcitabine

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Advanced Unresectable Pancreatic Cancer

Stopping Reasons

Preliminary data showed no survival benefit in the GV1001 group compared to the gemcitabine group.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID